Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
about
Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placeboThe Role of PPARs in CancerRegulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsUp-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomasSulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinomaProteasome inhibitors: their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cellsPancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCsChronic Inflammation Links Cancer and Parkinson's DiseaseIn vitro comparative models for canine and human breast cancersNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityCyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomasChrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activityp27 suppresses cyclooxygenase-2 expression by inhibiting p38β and p38δ-mediated CREB phosphorylation upon arsenite exposureThe brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cellsThe bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.Molecular characterization of human and rat organic anion transporter OATP-D15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerCyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatmentCyclooxygenase-2 and the inflammogenesis of breast cancer.Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.The influence of Cox-2 and bioactive lipids on hematological cancers.Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesionsCombination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.Cyclooxygenases: structural and functional insights.Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.Cox-2 gene expression in chemically induced skin papillomas cannot predict subsequent tumor fate.Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells.Dose-dependency of resveratrol in providing health benefits.Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterationsCyclooxygenase-2 inhibitor, celecoxib, inhibits leiomyoma cell proliferation through the nuclear factor κB pathway.Targeting angiogenesis with integrative cancer therapies.Immunotherapy for lung cancers.Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.Chronic Inflammation: Accelerator of Biological Aging.MLK3 is a novel target of dehydroglyasperin D for the reduction in UVB-induced COX-2 expression in vitro and in vivoAntinociceptive activities and the mechanisms of anti-inflammation of asiatic Acid in miceGastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 productionLung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammationCyclooxygenase-2 expression in hamster and human pancreatic neoplasiaPotential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.
P2860
Q21261269-9D30570E-0B21-4028-83AC-A446CAF63B5EQ21342955-8B093EE2-9FC8-4D65-B985-6A567E57D05CQ24631327-F47D1B43-3853-4337-B330-D2C27EC0DDF5Q24672036-B00B20E6-4351-4EBB-B43B-20629736959EQ24674087-B74BD2C2-8317-4D8D-ADED-10EC13D03C83Q24801210-A5CB14D3-E734-420F-B6C2-AD9879784DC4Q24812877-45C1E06E-5571-43BA-B5B9-A1D090695CAEQ26745344-61E67258-67DF-4AE9-AFFA-489379E9C8D0Q26752714-0BA6CA3B-A9D8-4ED9-BC31-0899C3833807Q28166312-03A3FCF3-C23E-4D08-B92F-C8B2A7E194A2Q28293433-FC7951DC-2E30-49F8-B9D6-D2473DC8033BQ28304235-FE286D4D-54D3-46BF-98E1-AED5EECA2259Q28384606-62122460-942F-43DA-8813-0D78FCB91D67Q28485319-2DBC01D9-A771-40FF-AC17-BF00849888F1Q28540582-97F7935B-E35F-4A85-8240-B4C7F75F43F9Q28572955-1098310A-60FC-4989-BA0E-1EEDF4957813Q28592082-46867B22-BA7A-463A-BA04-B28626375156Q28652149-C1457D30-CCCC-47D3-9CE8-9E02A704671AQ30367680-ABDB6B06-6C97-4E36-9863-9FEC713C7882Q33356757-382793EF-CF9D-4AF7-9ADE-4992E2BCED06Q33688673-184E867A-674D-48A2-829F-F0FC7F546002Q33868003-D3C60966-6AC2-4C95-8A59-232075031484Q33895607-F74B825F-63DC-41ED-BC62-46DCB301A7B5Q34014369-99A5F239-E732-4246-A8AA-DBCE63150EF0Q34015084-0821A4F5-7DB2-461C-BBA7-A553545B8D25Q34049932-E738E148-7B00-4D61-8540-7FA51D96C2F0Q34300048-C4E328F3-EA44-4B2A-A866-D2192D9E9CC6Q34341938-61B47114-0E9A-42FC-B572-0E24986D348BQ34390505-CD0C8207-AA41-42FC-BB22-9A8A5ED6AD36Q34418121-BACC87F1-8180-416C-A525-13824B96D71BQ34495463-295FD70C-8A5B-4DA9-B963-881069C20C4DQ34557611-5FEB7A04-6526-43E6-8E2E-8A6FE7D0AAD8Q34610297-C140A5A9-C979-4169-8DB2-0652AFA7E652Q34680346-55B8B767-38A7-4223-BE88-CDAF9A447ACFQ34885404-72C45CDA-6591-4BBC-961A-EED429EB8E97Q34975121-32B7A6AC-9CFD-4016-87DD-B1CDFEE29A01Q35048583-5D666628-F036-47EF-870D-D772AC9C88A5Q35070135-9A664497-0641-405D-971D-B82369C07FB5Q35082208-7F76E0DD-9A57-4677-A348-CD722A331D45Q35094458-C924DE71-EB53-4020-8A9D-B46503604EFC
P2860
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@ast
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@en
type
label
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@ast
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@en
prefLabel
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@ast
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@en
P1476
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
@en
P2093
Andrew J Dannenberg
Kotha Subbaramaiah
P304
P356
10.1016/S0165-6147(02)00043-3
P577
2003-02-01T00:00:00Z